EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors
Clinical trial NCT03481868 · UNKNOWN
Trial details
- NCT number
- NCT03481868
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2025-05-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.